FDA Drug Application (020539) for LAMISIL by NOVARTIS

Back to FDA Applications sponsored by NOVARTIS

Application Number020539
Product Number001
FormTABLET;ORAL
DosageEQ 250MG BASE
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB Products meeting necessary bioequivalence requirements
Reference Drug
Drug NameLAMISIL
Active IngredientTERBINAFINE HYDROCHLORIDE

Active IngredientCount
List of drugs with Active Ingredient TERBINAFINE2
List of drugs with Active Ingredient TERBINAFINE HYDROCHLORIDE3


Back to FDA Applications sponsored by NOVARTIS